Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-A(g7), which is also protective against the development of autoimmune diabetes

Diabetologia

Volumn 42, Issue 5, 1999, Pages 560-565

  Xu, X J ^a   Gearon, C ^a   Stevens, E ^a   Vergani, D ^a   Baum, H ^b   Peakman, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Class II MHC; GAD 65; I A(g7); NOD mice; Peptide therapy; T cells; Tolerance

Indexed keywords

GLUTAMATE DECARBOXYLASE; IA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0033043707     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051195     Document Type: Article

References (23)

1. Todd JA (1990) Genetic control of autoimmunity in type 1 diabetes. Immunol Today 11: 122-129
2. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J (1992) Dose effect of Cis- and Trans-encoded HLA-DQαβ heterodimers in IDDM susceptibility. Diabetes 41: 378-384
3. Todd JA, Altman TJ, Cornall RJ et al. (1991) Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351: 542-547
4. Nepom GT, Kwok WW (1998) Molecular basis for HLA-DQ associations with IDDM. Diabetes 47: 1177-1184
5. Altmann DM, Sansom D, Marsh SG (1991) What is the basis for HLA-DQ associations with autoiummune disease? Immunol Today 12: 267-270
6. Von Boehmer H (1994) Positive selection of lymphocytes. Cell 76: 219-228
7. Chicz RM, Urban RG, Lane WS et al. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358: 764-768
8. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178: 24-47
9. Marrack P, Ignatowicz L, Kappler JW, Boymel J, Freed JH (1993) Comparison of peptides bound to spleen and thymus class II. J Exp Med 178: 2173-2183
10. Reich EP, von Grafenstein H, Barlow A, Swenson KE, Williams K, Janeway CA Jr (1994) Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol 152: 2279-2288
11. Baum H, Davies H, Peakman M (1996) Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 15: 345-347
12. Baum H, Brusic V, Choudhuri K, Cunningham P, Vergani D, Peakman M (1995) MHC moleculear mimicry in diabetes. Nature Med 1: 388
13. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt DO (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75
14. Kaufman DL, Salzler CM, Tian J et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72
15. Gearon CL, Hussain MJ, Vergani D, Peakman M (1997) Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes. Diabetologia 40: 1388-1395
16. Elias D, Cohen IR (1994) Peptide therapy for diabetes in NOD mice. Lancet 343: 704-706
17. Tompkins SM, Rota PA, Moore JC, Jensen PE (1993) A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins. J Immunol Methods 163: 209-216
18. Honeyman MC, Stone NL, Harrison LC (1998) T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 4: 231-239
19. g7 β-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. J Immunol 154: 5567-5575
20. Ignatowicz L, Rees W, Pacholczyk R et al. (1997) T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 7: 179-186
21. Albani S, Keystone EC, Nelson JL et al. (1995) Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1: 448-452
22. Wildner G, Thurau SR (1994) Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol 24: 2579-2585
23. Thurau SR, Diedrichs-Mohring M, Fricke H, Arbogast S, Wildner G (1997) Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide cross-reactive with autoantigen-first results. Immunol Lett 57: 193-201.